XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Changes in Shareholders' Equity - USD ($)
Total
Class A ordinary shares [Member]
Class B ordinary shares [Member]
Common Stock [Member]
Class A ordinary shares [Member]
Common Stock [Member]
Class B ordinary shares [Member]
Additional Paid-in Capital
Accumulated Deficit
Rocket Lab USA, Inc.
Rocket Lab USA, Inc.
Redeemable Convertible Preferred Stock [Member]
Rocket Lab USA, Inc.
Common Stock [Member]
Rocket Lab USA, Inc.
Additional Paid-in Capital
Rocket Lab USA, Inc.
Accumulated Deficit
Rocket Lab USA, Inc.
AOCI Attributable to Parent [Member]
Balance at Beginning at Dec. 31, 2018               $ (93,011,000) $ 254,460,000   $ 9,651,000 $ (102,326,000) $ (336,000)
Balance at Beginning (in Shares) at Dec. 31, 2018                 30,680,373 7,924,028      
Net loss               (30,360,000)       (30,360,000)  
Exercise of stock options               $ 655,000     655,000    
Exercise of stock options (in Shares)               152,247   152,247      
Stock-based compensation               $ 3,930,000     3,930,000    
Issuance of common stock warrant               769,000          
Other comprehensive income               257,000         257,000
Balance Ending at Dec. 31, 2019               (118,529,000) $ 254,460,000   14,236,000 (132,686,000) (79,000)
Balance Ending (in Shares) at Dec. 31, 2019                 30,680,373 8,076,275      
Issuance of Series E-1redeemable preferred stock for cash                 $ 20,500,000        
Issuance of Series E-1redeemable preferred stock for cash (in Shares)                 650,140,000        
Net loss               (23,453,000)       (23,453,000)  
Exercise of stock options               22,000     22,000    
Exercise of stock options (in Shares)                   10,506,000      
Stock-based compensation               1,923,000     1,923,000    
Issuance of common stock for business combination (Shares)                   272,727,000      
Other comprehensive income               (367,000)         (367,000)
Balance Ending at Jun. 30, 2020               (140,404,000) $ 274,960,000   16,181,000 (156,139,000) (446,000)
Balance Ending (in Shares) at Jun. 30, 2020                 31,330,513 8,359,508      
Issuance of Series E-1redeemable preferred stock for cash                 $ 20,500,000        
Issuance of Series E-1redeemable preferred stock for cash (in Shares)                 650,140        
Balance at Beginning at Dec. 31, 2019               (118,529,000) $ 254,460,000   14,236,000 (132,686,000) (79,000)
Balance at Beginning (in Shares) at Dec. 31, 2019                 30,680,373 8,076,275      
Net loss               (55,005,000)       (55,005,000)  
Exercise of stock options               $ 978,000     978,000    
Exercise of stock options (in Shares)               305,867   305,867      
Stock-based compensation               $ 4,218,000     4,218,000    
Issuance of common stock for business combination (Shares)                   272,727      
Issuance of common stock warrant               496,000     496,000    
Other comprehensive income               1,134,000         1,134,000
Balance Ending at Dec. 31, 2020 $ 5,000,004 $ 397 $ 800 $ 397 $ 800 $ 17,340,758 $ (12,341,951) (166,708,000) $ 274,960,000   19,928,000 (187,691,000) 1,055,000
Balance Ending (in Shares) at Dec. 31, 2020   3,974,267 8,000,000 3,974,267 8,000,000       31,330,513 8,654,869      
Balance at Beginning at Jul. 27, 2020 0     $ 0 $ 0 0 0            
Balance at Beginning (in Shares) at Jul. 27, 2020       0 0                
Balance at Beginning at Jul. 27, 2020 0     $ 0 $ 0 0 0            
Balance at Beginning (in Shares) at Jul. 27, 2020       0 0                
Issuance of Class B ordinary shares to Sponsor 25,000       $ 863 24,137              
Issuance of Class B ordinary shares to Sponsor (in Shares)         8,625,000                
Sale of 32,000,000 Units, net of underwriting discounts, offering costs, and warrant liabilities 293,547,618     $ 3,200   293,544,418              
Sale of 32,000,000 Units, net of underwriting discounts, offering costs, and warrant liabilities (in Shares)       32,000,000                  
Excess of proceeds from the sale of private placement warrants to Sponsor 4,026,667         4,026,667              
Forfeiture of Founder Shares         $ (63) 63              
Forfeiture of Founder Shares (in Shares)         (625,000)                
Class A ordinary shares subject to possible redemption (280,257,330)     $ (2,803)   (280,254,527)              
Class A ordinary shares subject to possible redemption (in Shares)       (28,025,733)                  
Net loss (12,341,951)           (12,341,951)            
Balance Ending at Dec. 31, 2020 5,000,004 $ 397 $ 800 $ 397 $ 800 17,340,758 (12,341,951) (166,708,000) $ 274,960,000   19,928,000 (187,691,000) 1,055,000
Balance Ending (in Shares) at Dec. 31, 2020   3,974,267 8,000,000 3,974,267 8,000,000       31,330,513 8,654,869      
Class A ordinary shares subject to possible redemption 23,560,260 $ 236       23,560,024              
Class A ordinary shares subject to possible redemption (in Shares)   2,356,026                      
Net loss (23,560,263)         (23,560,263)              
Balance Ending at Mar. 31, 2021 5,000,001 $ 633 $ 800     40,900,782 (35,902,214)            
Balance Ending (in Shares) at Mar. 31, 2021   6,330,293 8,000,000                    
Balance at Beginning at Dec. 31, 2020 5,000,004 $ 397 $ 800 $ 397 $ 800 17,340,758 (12,341,951) (166,708,000) $ 274,960,000   19,928,000 (187,691,000) 1,055,000
Balance at Beginning (in Shares) at Dec. 31, 2020   3,974,267 8,000,000 3,974,267 8,000,000       31,330,513 8,654,869      
Forfeiture of Founder Shares (40,000,000)                        
Net loss (24,619,357)             (32,547,000)       (32,547,000)  
Exercise of stock options               772,000     772,000    
Exercise of stock options (in Shares)                   85,153,000      
Stock-based compensation               2,379,000     2,379,000    
Other comprehensive income               1,074,000         1,074,000
Balance Ending at Jun. 30, 2021 (59,362,023)   $ 800       (59,362,823) (195,030,000) $ 274,960,000   23,079,000 (220,238,000) 2,129,000
Balance Ending (in Shares) at Jun. 30, 2021     8,000,000           31,330,513 8,740,022      
Balance at Beginning at Mar. 31, 2021 5,000,001 $ 633 $ 800     40,900,782 (35,902,214)            
Balance at Beginning (in Shares) at Mar. 31, 2021   6,330,293 8,000,000                    
Class A ordinary shares subject to possible redemption (63,302,930) $ (633)       $ (40,900,782) (22,401,515)            
Class A ordinary shares subject to possible redemption (in Shares)   (6,330,293)                      
Net loss (1,059,094)           (1,059,094)            
Balance Ending at Jun. 30, 2021 $ (59,362,023)   $ 800       $ (59,362,823) $ (195,030,000) $ 274,960,000   $ 23,079,000 $ (220,238,000) $ 2,129,000
Balance Ending (in Shares) at Jun. 30, 2021     8,000,000           31,330,513 8,740,022